BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5547274)

  • 1. On thelipoprotein abnormality in type 3 hyperlipoproteinemia.
    Quarfordt S; Levy RI; Fredrickson DS
    J Clin Invest; 1971 Apr; 50(4):754-61. PubMed ID: 5547274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of behaviour of very low density lipoproteins of type III hyperlipoproteinaemia on electrophoresis on paper and on agarose gel with a note on a late (slow) pre-beta VLDL liproprotein.
    Carlson K; Carlson LA
    Scand J Clin Lab Invest; 1975 Nov; 35(7):655-60. PubMed ID: 174185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Typing of hyperlipoproteinemia in an Israel hospital.
    Eisenberg S
    Isr J Med Sci; 1976 Nov; 12(11):1261-8. PubMed ID: 1017927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.
    Packard CJ; Munro A; Lorimer AR; Gotto AM; Shepherd J
    J Clin Invest; 1984 Dec; 74(6):2178-92. PubMed ID: 6511922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spectrum of electrophoretic mobility of very low density lipoproteins: role of slower migrating species in endogenous hypertriglyceridemia (type IV hyperlipoproteinemia) and broad-beta disease (type III).
    Hazzard ER; Bierman EL
    J Lab Clin Med; 1975 Aug; 86(2):239-52. PubMed ID: 168277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and compositional changes attending the ultracentrifugation of very low density lipoproteins.
    Herbert PN; Forte TM; Shulman RS; La Piana MJ; Gong EL; Levy RI; Fredrickson DS; Nichols AV
    Prep Biochem; 1975; 5(2):93-129. PubMed ID: 167365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on serum lipoproteins of rats developing spontaneous hyperlipidemia.
    Gustafsson K; Kiessling H
    Artery; 1981; 9(6):456-76. PubMed ID: 7337554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
    Manzato E; Marin R; Gasparotto A; Baggio G; Fellin R; Crepaldi G
    J Lab Clin Med; 1984 Nov; 104(5):778-88. PubMed ID: 6491471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation-induced changes in rabbit CRP and plasma lipoproteins.
    Cabana VG; Gewurz H; Siegel JN
    J Immunol; 1983 Apr; 130(4):1736-42. PubMed ID: 6833752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
    Kushwaha RS; Chait A; Hazzard WR
    J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J; Bar-On H; Shafrir E
    Isr J Med Sci; 1981 Nov; 17(11):1001-8. PubMed ID: 7319786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxandrolone and plasma triglyceride reduction: effect on triglyceride-rich and high density lipoproteins.
    Hara T; Miller JP; Gotto AM; Patsch JR
    Artery; 1981; 9(5):328-41. PubMed ID: 7316782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacement of carbohydrate by protein in a conventional-fat diet reduces cholesterol and triglyceride concentrations in healthy normolipidemic subjects.
    Wolfe BM; Piché LA
    Clin Invest Med; 1999 Aug; 22(4):140-8. PubMed ID: 10497712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlative design of electrophoretic and ultracentrifugal investigation of metabolic effects of probucol.
    Opplt JJ; Chick LL; Opplt MA
    Artery; 1982; 10(2):131-49. PubMed ID: 7092580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of lipoprotein metabolism impairments in nephrotic syndrome].
    Titov VN; Tvorogova MG; Levitova EN; Krylova EA
    Vopr Med Khim; 1983; 29(2):17-23. PubMed ID: 6858031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of beta-pyridylcarbinol on lipids and lipoprotein in primary type IIa hyperlipoproteinemia].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(12):1682-4. PubMed ID: 6686774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
    Ybarra J; James RW; Makoundou V; Bioletto S; Golay A
    Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative comparison of lipoprotein electrophoresis on cellulose acetate membranes with fractionation of lipoproteins in the preparative ultracentrifuge. Lipoprotein electrophoresis on cellulose acetate membranes].
    Klemens UH; Schmalbeck J
    Z Klin Chem Klin Biochem; 1970 Mar; 8(2):166-9. PubMed ID: 5421236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.